Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations.
about
Role Played by Signalling Pathways in Overcoming BRAF Inhibitor Resistance in Melanoma.Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study.Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol.Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer.Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases
P2860
Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations.
@en
Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations.
@nl
type
label
Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations.
@en
Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations.
@nl
prefLabel
Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations.
@en
Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations.
@nl
P2093
P2860
P921
P356
P1476
Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations.
@en
P2093
Karen Bedard
Nourah Mohammad Obaid
Weei-Yuarn Huang
P2860
P356
10.3390/IJMS18030585
P407
P5008
P577
2017-03-08T00:00:00Z